Erik Tambuyzer
Directeur/Bestuurslid bij Augustine Therapeutics NV
Actieve functies van Erik Tambuyzer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Augustine Therapeutics NV
 Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Directeur/Bestuurslid | 19-03-2021 | - |
Loopbaan van Erik Tambuyzer
Opleiding van Erik Tambuyzer
| Katholieke Universiteit Leuven | Doctorate Degree |
Statistieken
Internationaal
| België | 3 |
Operationeel
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Services | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Augustine Therapeutics NV
Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Health Services |
- Beurs
- Insiders
- Erik Tambuyzer
- Ervaring
